By switaschek, 15 October, 2020 Lung Cancer Screening in Asymptomatic Pts | USPSTF, ACCP, ACS, AATS, etc. Guideline Synthesis
By rray, 30 September, 2024 If pt didn t receive bismuth quadruple tx BQT or optimized BQT as 1st line tx Optimized BQT preferred 1
By rray, 30 September, 2024 If pt didn t receive bismuth quadruple tx BQT or optimized BQT as 1st line tx Optimized BQT preferred 1
By rray, 30 September, 2024 If pt didn t receive bismuth quadruple tx BQT or optimized BQT as 1st line tx Optimized BQT preferred 1
By rray, 30 September, 2024 If pt received 1st line tx containing clarithro Optimized bismuth quadruple tx is preferred 1
By rray, 30 September, 2024 If pt received 1st line tx containing clarithro Optimized bismuth quadruple tx is preferred 1 nbsp nbsp If bismuth or tetracycline unavail Rifabutin triple tx is suitable alternative If pt can t take rifabutin e g due to true PCN allergy conduct susceptib